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LASTING SOCIAL DEFICITS MEDIATED BY RECURRENT  
PENTYLENETETRAZOLE-INDUCED SEIZURES IN MICE 
SALLY A. PETERSON  
ABSTRACT 
 Autism is a neurodevelopmental disorder characterized by core impairments in 
social reciprocity and communication, together with a repetitive/restricted pattern of 
behavioral interests. Up to a third of individuals with autism also suffer from epilepsy, 
and human cross-sectional studies have demonstrated that the co-existence of epileptic 
seizures tends to result in more severe autistic phenotypes. It remains unknown as to 
whether this phenomenon is a result of anticonvulsant medications, the underlying autism 
promoting insult or the effect of recurrent seizures themselves. In an attempt to establish 
a connection between recurrent seizures and their impact on social behavior, we designed 
a simple and reliable mouse model of recurrent seizures by employing daily 
intraperitoneal injections of the chemoconvulsant PTZ (pentylenetetrazole, a GABA 
antagonist). Social motivation was assayed on the three-chamber social interaction test.  
We observed that 24 hours following 10 daily injections of a subconvulsant dose of PTZ 
(30mg/kg), both male and female mice display a reduction in social interaction. Mice 
exposed to seizures also vocalized significantly less than control mice. These social 
impairments were not related to a gross impairment in locomotion, olfaction, or 
exploration and were found to persist up to 30 days following their last seizure. These 
results suggest that recurrent seizures themselves may be facilitating some of the 
heightened social deficits frequently seen with autism and epilepsy. These results also 
	  	   vi 
lend naturally to i) studies examining molecular and structural neuroplastic changes 
occurring in brain circuits that are important for social behavior, and ii) data that may 
highlight the contributions of specific genes that may accelerate or protect against the 
development of seizure-induced impairments in social behavior.  
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INTRODUCTION 
 
Autism is a neurodevelopmental disorder characterized by three hallmark traits 
that are seen throughout the population and used as part of the diagnostic criteria: 
impairments in social interaction, communication, and frequent restricted, repetitive 
behaviors (Ellerbeck et al., 2015). As with many complex neurodevelopmental disorders, 
patients can display a wide spectrum of severity of illness, giving rise to the term 
“autism-spectrum disorders” (ASDs). Since the early 1940s, knowledge of the etiology 
and features of autism spectrum disorders has grown tremendously, but there are still 
several aspects of autism that have eluded the scientific community. There is some 
evidence to suggest that the prevalence of this disorder is increasing: in 2008, the Center 
for Disease Control estimated that 1 in 88 children in the U.S. met the criteria for an 
autism diagnosis by the DSM-IV criteria set forth by the American Psychiatric 
Association. As of March of 2010, that number had grown to 1 in 68; a 30% increase in 2 
years (Wingate et al., 2012). The increase in incidence may be related to a number of 
factors, including heightened awareness, societal programs designed to aid in the early 
and efficient diagnosis of the disease, and changes in diagnostic criteria seen across the 
world (Hansen et al., 2015). The requirement for frequent behavior and occupational 
therapy sessions, medications and frequent hospitalization for these patients results in not 
only an emotional cost to patients and their caregivers, but also an astronomical societal 
expense. In 2011, the total societal costs for providing care for children with ASDs 
reached $11.5 billion dollars (Lavelle et al., 2014).  
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In addition to the phenotypic variance of the illness, there remains a considerable 
degree of etiological heterogeneity believed to underlie the illness. A number of 
environmental factors have been proposed to contribute to autistic traits, including 
advanced paternal age, maternal infections during pregnancy, and exposure to heavy 
metals (Lee & McGrath, 2014; Yassa, 2014; Mazina et al., 2015). The diagnosis of ASDs 
is completely behavioral based and does not have a singular cause or warning signal. 
However, it is known that the disorder is highly heritable (Smith et al., 2011). The 
particularly high heritability of this illness has given rise to our understanding of 
important genetic aspects made apparent in previous twin studies, which have shown that 
monozygotic twins are 70-90% more likely to present with ASDs than dizygotic twins 
(Abrahams & Geschwind, 2008). In the last decade, researchers have attempted to find a 
root cause of ASDs in order to standardize treatments and diagnoses, but have realized 
that there is an entire spectrum of genetic mutations, medical conditions, and unknown 
factors that lead to ASDs (Smith et al., 2011). Additional linkage and genetic association 
studies have revealed a number of genetic mutations and chromosomal number variants 
(CNVs) that have been implicated as causative factors in patients affected by this illness. 
A significant portion of these genes are involved in synaptic function, strength, and 
organization (Glessner et al., 2009; Betancur et al., 2009). Known medical 
neurodevelopmental syndromes such as Fragile X, Retts Syndrome, and Tuberous 
sclerosis contribute to only approximately 10-20% of overall cases of ASDs (Spence and 
Schneider, 2009). Ultimately, the expression of the illness may be a result of the 
interaction between low penetrance genetic mutations and environmental exposures, 
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further complicating epidemiological studies designed to identify specific causative 
factors.  
Another complication of establishing the parameters of the disorder are frequent 
comorbid disorders such as epilepsy, the most common serious childhood neurological 
disorder (Reilly et al., 2014). Epilepsy is characterized by the tendency to develop 
recurrent, unprovoked seizures (Tuchman et al., 2009). Patients with ASD can display 
seizures as a part of a range of diverse epilepsy syndromes (Berg & Plioplys, 2012). 
Several studies have been done to determine the percentage of patients who live with 
epilepsy and comorbid autism, but have come up with a wide range of values from 5-46% 
(Spence and Schneider, 2009) as compared to the prevalence of epilepsy in patients not 
affected with autism, which is estimated at 2-3% (Tuchman & Rapin, 2002). Comorbid 
epilepsy may increase the severity of autistic endophenotypes observed in patients with 
ASD. In one study (Hartley-McAndrew & Weinstock, 2010), investigators 
retrospectively reviewed EEG (electroencephalography) data to identity small cohorts of 
patients with autism that either did or did not have epileptiform EEG abnormalities 
(electrographic changes associated with a higher propensity to develop seizures). 
Children with autism who also had a history of seizure events displayed significantly 
lower scores in the Vineland Adaptive Behavior Scale II (VABS), which measures 
adaptability of patients to new environments and situations, as well as socialization 
questionnaires. They also found that these children presented with higher levels of 
hyperactivity and irritability. Similarly, Turk and colleagues showed that patients with 
ASD and comorbid epilepsy were more likely to show motor difficulties, developmental 
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delay and challenging behaviors compared with a matched sample of patients with ASD 
alone (Turk et al., 2009). 
The relationship between autism and epilepsy is clearly more complicated. An 
important confounding factor in these studies may be the co-occurrence of intellectual 
disability, common to a range of neurodevelopmental syndromes, and which may also 
result in impairments in social communication and interaction. At the other end of the 
spectrum, some studies suggested that autism itself was associated with a higher 
prevalence of epilepsy (Spence and Schneider, 2009) and a host of other aspects such as 
IQ, other neurogenetic disorders, age, developmental regression, and gender (Spence and 
Schneider, 2009). They felt that numerous biases might be impacting the current research 
and report of severity or prevalence of epilepsy in ASDs, especially due to referral bias 
by epilepsy clinics. In this regard, another cross-sectional observational study 
demonstrated that patients with ASD and epilepsy had significantly more autism 
symptoms and maladaptive behaviors, but after correcting for intellectual disability (by 
measuring IQ levels), this relationship did not hold true (Viscidi et al., 2013). Even with 
population-based studies, the rates of reported ASDs and epilepsy are all over the map at 
5-26% (Spence and Schneider, 2009). Thus, comorbid intellectual disability itself in 
patients with ASDs may be a risk factor for exhibiting epileptic symptoms (Caplan & 
Austin, 2000). Other concerns of theirs involved inclusion of non-idiopathic autism cases 
in case studies. These cases included known conditions such as Tuberous sclerosis 
complex (TSC), Retts syndrome, or even CNVs. Individual differences amongst patients 
may also be a confounding factor when using patient cases to find answers. (Spence and 
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Schneider, 2009). The age of onset of seizures may also play a role in determining the 
magnitude of the impact of epilepsy on autistic behaviors (Lugo et al., 2014). While 
controlled prospective studies examining these parameters in humans are lacking, 
chemically induced seizures in 7-day old mice were shown to subsequently result in 
abnormal measures of social behavior and memory during adulthood (Lugo et al., 2014). 
These data exemplify the importance of neural circuit changes in early developmental 
critical periods in the expression of normal adult social interaction, and demonstrate 
dysregulated neuronal activity during this time period can result in significant changes in 
emotional behavior (Jensen, 2011). 
Due to the complexity of both of these disorders, retrospective or prospective 
clinical studies are often inconclusive or hindered by conflicting factors. Some small 
clinical studies have suggested that patients with epilepsy present with worse ASD 
behavioral symptoms as compared to children with ASD alone (Turk et al., 2009). That 
particular study found important between-group differences for patients with ASDs 
versus patients with ASDs and epilepsy. The children that suffered from both disorders 
had significantly worse motor difficulties, developmental delays, and challenging 
behaviors (Turk et al., 2009). Overall, those children also received later diagnoses of 
ASD than children with ASD alone, which could have resulted in receiving treatment and 
care much later in life (Turk et al., 2009).  Other retrospective studies have shown that 
autistic regression, a loss of previously gained proficiency in social, language, or 
attachment behaviors (Rogers, 2004), may be a specific feature of autism associated with 
epilepsy (Oslejkova et al., 2008). However, their regression-epilepsy hypothesis was 
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confined to behavioral regression and not speech (Oslejkova et al., 2008), further 
complicating the relationships between epilepsy and ASD behavior. Ultimately, a key 
question that remains unanswered from the available clinical and scientific literature is 
whether the recurrent seizures associated with epilepsy are themselves sufficient to 
produce an autistic syndrome (or to augment the expression of autistic features in an 
individual with a prespecified autism risk factor). In the absence of high quality long-
term prospective clinical studies that closely monitor intellectual functioning, autistic 
behavior, as well as both seizure occurrence, and epileptiform EEG abnormalities, this 
remains an unanswered question. 
In the experiments described below, our objective was to shed light on this 
problem by employing laboratory mice, which have served as an important model in 
recent years to understand core neurobiological abnormalities in human autism. Social 
behavior in mice can be studied using a number of tests, including the three-chamber 
social interaction test, developed by Crawley and colleagues. Social interaction deficits 
are often modeled in mice by presenting mice with a social choice task in which they can 
choose to spend time in close proximity to another mouse or alone (Moy et al., 2008). 
Crawley and colleagues design aimed to do just that. In their design, mice are allowed to 
freely explore a 3-chambered box for five minutes. Mice are then exposed to a second 5 
minute trial in which they can choose to interact with a novel, stranger mouse or spend 
time alone within the same 3-chambered box. Interacting in a social context has been 
established as an innate mouse behavior across multiple different backgrounds of mice 
(Moy et al., 2008) suggesting that in general, mice are social animals that prefer to spend 
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significantly more time near other mice rather than alone (Moy et al., 2008). Not all 
strains of mice had such a clear preference for spending time in close proximity of other 
mice and some exhibited significantly higher levels of anxiety (Moy et al., 2007); 
however, the WT FVB mice that were used in our study were found to have a clear social 
preference in their normal, wild type background in that particular study. Moy et al. only 
used male mice in their study across backgrounds, so it would be beneficial to confirm 
that this social preference remains for female mice, but is assumed to remain constant 
across sexes. For our purposes, we used this assay to observe the social choices mice 
make after being exposed to recurrent seizures. 
Ultrasonic vocalization (USV) recordings are a relatively new way of testing 
verbal communication in a social environment in mice. Zippelius and Schleidt originally 
adapted USV recordings in 1956, to study mother/pup relationships and interactions, 
which have long been labeled as communicative behavior in mice (Scattoni, 2011). 
Mouse pups frequently emit USVs in response to cold exposure, isolation, and/or 
handling and are used to communicate with the mother (Ricceri et al., 2007); however, 
USV emission in many strains persists into adulthood (Ricceri et al., 2007). The meaning 
of pup USVs is a highly debated topic, but is generally regarded as a signal of emotional 
distress or anxiety (Hofer, 2002). It is generally accepted that pup USVs convey more 
information than just whether or not the pup is stressed or anxious; mainly because the 
pup’s vocalizations elicit a response from the sire of the litter, which suggests a higher 
purpose (Panksepp, 2003). USVs are now being used to study social behavior in adult 
mice (Scattoni et al., 2009). Since its inception, USV recording analysis has developed 
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significantly and is now not only quantifiable but also qualitatively measurable (Scattoni 
et al., 2009). Depending upon the age of the mouse and the context in which the mouse is 
vocalizing, vocalizations of different shapes are produced on the acoustic transcript. 
Many researchers believe that these shapes and frequency changes signify a sort of 
syllable-based “language” that communicates intention to the other mice (Portfors, 2007). 
Male and female mice tend to vocalize in response to different social stimuli (Ricceri et 
al., 2007). When sexually mature male mice are paired with unfamiliar female mice, a 
ritual mating “song” that is important for reproductive behaviors if often elicited (Holy & 
Gou, 2005). Maggio and Whitney were the first to study female-female specific USVs in 
1985. They found that female pairs vocalize comparably to male-female pairs. As 
research into the qualitative aspects of USV emission (i.e., the shape of the USV 
emission) remains an interesting area of ongoing research, a number of laboratories have 
demonstrated how genetic mouse models of autism display quantitative changes 
(reductions) in mouse vocalizations as adults, mimicking the vocal communication 
deficits seen in neurodevelopmental disorders such as ASD (Kas et al., 2014).  
Do recurrent seizures alone in mice produce impairments in social preference? 
Preliminary experiments using the pilocarpine status epilepticus (PSE) model suggest that 
this may indeed be the case. The PSE model involves the generation of status epilepticus 
(defined as a prolonged seizure lasting > 5 minutes, or multiple seizures in a short time 
frame without return to baseline normal behavior), through the injection of the 
muscarinic agonist, pilocarpine. Following 40-60 minutes of continuous seizure activity, 
status is aborted by the injection of a benzodiazepine or barbiturate agent. Following a 
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latent period of approximately 10-20 days, mice go on to display spontaneous recurrent 
seizures associated with a range of specific hippocampal cytomorphological 
abnormalities, including mossy fiber sprouting (Curia et al. 2008). In Seo et al, mice that 
were exposed to this protocol displayed impaired sociability (decreased social preference) 
on the 3-chamber social interaction test in both the latent and chronic seizure periods that 
was not explained by decreased exploration or altered locomotion (Seo et al., 2013). The 
PSE model remains an important and valuable research tool for studying the 
neurobiology of epilepsy, and in particular temporal lobe epilepsy. But as it pertains to 
studying social behavior, and in particular how genetic influences on how seizures may 
impact social behavior, this particular chemoconvulsant model does have some critical 
weaknesses. First, the mortality associated with the induction of status epilepticus can be 
as high as 40% (Jiang et al., 2013), which remains an unacceptably high fraction, given 
today’s costs and resources required to breed, characterize, and genotype mutant mice. 
Secondly, while the generation of spontaneous recurrent seizures clearly enhances the 
face validity of this technique as a model of epilepsy, spontaneous seizures experienced 
by mice exposed to the PSE protocol can occur at any time of the day, including during 
or just preceding behavioral testing. This clearly complicates behavioral testing requiring 
investigators to either i) exclude animals that display a seizure during the testing protocol 
and/or ii) assume that the time elapsed between testing and their most recent seizure is 
approximately identical in all animals, an assumption that may not be true. Therefore, we 
chose to employ a lesser-used but important chemoconvulsant, pentylenetetrazole (PTZ). 
PTZ is a fast acting GABA antagonist, which when injected into mice through either 
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intraperitoneal or subcutaneous routes, results in a spectrum of absence seizures, 
myoclonic seizures and generalized tonic seizures (Dhir et al, 2012).  Specifically, the 
administration of repeated subconvulsant doses of PTZ (~20-30mg/kg) has been shown 
by us and several other groups to lead to a progressive increase in the severity of seizures 
(kindling), (McNamara, 1984; Zhou et al., 2009), a phenomenon believed to contribute to 
the progression of epilepsy in at least a proportion of patients (Hauser & Lee, 2002).  
Our goal was to establish a new protocol for the chemical kindling of mice using 
a revised 10-day injection cycle with behavioral testing on the 11thand 40th days post-
seizures. Using this protocol, we wanted to determine whether recurrent seizures in WT 
FVB male and female mice were sufficient to create lasting deficits in social behavior, 
specifically the social behaviors associated with autism. We hypothesized that mice who 
had been subjected to the 10-day seizure protocol, would display significantly decreased 
USVs when placed in a social context. We also predicted that there would be a loss of 
social preference and that the mice would spend less time with the stranger mouse and 
more time alone. We used the buried food test to ensure that the seizures or any part of 
our experiment had not damaged the vomeronasal system that could cause a decrease in 
social interaction due to the importance of olfaction for social behavior in mice. Finally, 
we speculated that the mice exposed to seizures would not display inhibited motor 
function or heightened anxiety.  
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METHODS  
 
Mice  
 Wild type male and female mice of the FVB strain bred within Beth Israel 
Deaconess Medical Center were used for all experiments. Mice were between the ages of 
8-12 weeks. Mice were always group housed (up to 5/cage) with free access to standard 
laboratory chow and water. All mice were maintained in the barrier animal facility of the 
Center for Life Sciences (3 Blackfan Circle, Boston, MA 02115) in a 12h ON/OFF light 
cycle with lights ON at 6AM. For all experiments, n=7-10/group unless otherwise 
specified. All experimental protocols were approved by the Beth Israel Deaconess 
Medical Center Institutional Animal Care and Use Committee (IACUC). 
 
PTZ Injections 
Pentylenetetrazole (Sigma, St. Louis, MO) was dissolved in 0.9% normal saline to 
a final concentration of 3mg/ml, and administered once daily to wild type FVB mice at an 
injection volume of approximately 10ml/kg resulting in a final dose of 30mg/kg. 
Injections were administered approximately between 10:00 A.M. and 2:00 P.M. daily. 
PTZ seizure phenotypes were scored based on the protocol developed by Ferraro et al., 
1999, and were as follows: 
1) Phase 1. Hypoactivity. Animals received a score of 1 if they presented with 
slowed motor function and mobility often accompanied by their abdomens 
resting on the cage bottom.  
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2) Phase 2. Partial Clonus. Clonic jerks or seizure activity that affected the face, 
head, and limbs that lasted for 1-2 seconds.  
3) Phase 3. Generalized Clonus. Characterized by sudden whole body clonus and 
loss of upright posture. All four limbs and tail must be involved in order to 
classify as stage 3. Stage 3 clonus typically lasted between 30-60 seconds and 
was followed by a highly immobile postictal phase.  
4) Phase 4. Tonic-clonic (maximal) seizure. Animals with a score of 4 presented 
with all phase 3 symptoms, but experienced tonic hind limb extension and 
were almost always associated with death.  
 Each day after injection, mice were placed back into their home cages and 
allowed to recover until the next day. Behavioral measures were taken on day 11 of the 
protocol on which they received no injections. The protocol is depicted below in Figure 
1. All behavioral testing was performed either 24-hours after the last seizure (labeled 
“Day 11”) or 30 days following the last injection (“Day 40”). PTZ-induced seizure 
associated mortality varied between experiments, but was no greater than 10-20% 
overall.  
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Figure 1: PTZ Injection Protocol. Each red circle represents an IP injection of 
30mg/kg, which was given daily for 10 days. On day 11, social interaction time was 
measured.  
 
Social Behavior Measurements  
 A. 3-Chamber Social Interaction  
 The 3-chamber social interaction protocol was performed as previously described 
(Smith et al., 2011). Mice were moved from their home cage room to the behavioral 
testing room and were allowed to acclimate to their new surroundings for approximately 
30-60 minutes. The testing apparatus included: a clear plastic box that was organized into 
3 rectangular sections of equal dimensions, which were connected by doorways to allow 
for free exploration (Figure 2). The two outside chambers also had identical, circular, 
metal cages in order to house the stranger mouse during the acquisition phase. Each cage 
had a beaker filled with water placed on top in order to prevent climbing and tipping of 
the cage. Between each trial, the cages and chambers were cleaned using Clidox. Two 
five-minute trials were conducted: in the “acclimation” trial, the mouse was placed into 
the arena and allowed to freely explore the arena and empty wire cages. During the 
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“social trial”, an age and sex matched stranger mouse was placed in one of the wire metal 
cages (with its side alternated to avoid a side bias). Once the stranger mouse was placed 
in the cage, the test mouse was placed back in the center chamber of the apparatus. A 
ceiling mounted camera in combination with video tracking software (Noldus Ethovision) 
was employed to measure the distance moved during testing. In addition to tracking data, 
live scoring of behavior was also completed by using stopwatches to track the time spent 
“actively engaging” or “sniffing” with either the stranger mouse (social) or the empty 
cage (opposite).  
 
Figure 2: 3-Chamber Social Task. A clear, plastic box measuring 50 x 100 cm was 
used and fitted with two dividers (10 x 10 cm) to create 3 equally sized chambers.  
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Figure 3: Social Choice Sniffing Time. Social interaction was measured as “active 
sniffing” time. Interaction was only counted when the mouse was noted to be actively 
interacting with the social target mouse, as well as while the mouse was climbing on the 
cage.  
 
B. Ultrasonic Vocalization  
 WT FVB male and female mice aged 8-12 weeks were group housed in single-sex 
cages and provided with ample access to food and water except during the experiment. 
The apparatus built by our lab was a large, plastic storage container with an ultrasonic 
microphone and camera fitted into the lid (Figure 4). The container was lined with egg-
crate foam to dampen any external sounds. A small open plastic box was used inside to 
house the test mice and was covered by a cage lid that had the filter removed to prevent 
escape and to promote interaction between test mice. The camera and microphone were 
connected to USV emission interface software (Avisoft), which was adapted to record 
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and analyze mouse ultrasonic vocalizations. Each test recorded USVs for a duration of 5 
minutes and the testing box was cleaned after each trial using Clidox. The test mouse was 
placed in the small, removable clear box and placed into the apparatus. Male and female 
mice were paired with stranger female mice based on previous vocalization studies 
(Scattoni et al., 2009 and Wohr & Schwarting, 2013). Stranger females were used in a 
rotating manner with each male and female test subjects. The assigned female was then 
placed in the box with the mouse and both lids were securely closed. The recording 
commenced and ran for 5 minutes. Vocalizations measured in these encounters were 
analyzed for mean duration, total duration, total number of events, minimum duration, 
and maximum duration.  
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Figure 4: Ultrasonic Vocalization Recording Arena. Mice were placed in a small, 
plastic box inside a larger soundproof container. An ultrasonic microphone was mounted  
to the top of the container and recorded vocalizations. Avisoft Bioacoustic software 
connected to the camera collected and analyzed recordings for 5 minutes.   
 
Olfaction  
 The olfaction protocol was adapted from Yang & Crawley (2009). All mice were 
food deprived for at least 24-hours in their home cages with access to water. Mice were 
moved from their home cage room to the testing room and were allowed to acclimate to 
their new surroundings for approximately 30-60 minutes. New, empty cages were used as 
temporary housing during the experiment. Each cage was given extra bedding in order to 
create a 3 cm layer. The metal food grate was removed from each cage and a chocolate 
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chip teddy graham treat was buried in the same place, at the same depth in each cage. 
Mice were then placed into each cage and were observed for a maximum of 15 minutes. 
Using a stopwatch, the observer recorded the time it took for the mouse to find the cookie 
and/or consume the treat. Mice that did not find the buried food item within 10 minutes 
were excluded from the study.   
 
Open Field Test  
  
 For the open field test, we used a square, wooden box with an open top (Figure 5). 
An automated system of tracking was used to observe and calculate mouse movements as 
well as time spent in specific regions of the open box that were previously designated as 
the “center”. Mice were moved from their home cage room to the testing room and were 
allowed to acclimate to their new surroundings for approximately 30-60 minutes. Each 
mouse was placed in the arena for 10 minutes. Videotracking software and a ceiling 
mounted camera helped us track the movement of the mouse during the 10-minute trial. 
The arena was cleaned with Clidox between every trial. 
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Figure 5. Open Field. Mouse motor function and exploration.  
Statistics 
Two tailed student’s T testing was used for all comparisons between two groups, 
with p<0.05 set as criteria for statistical significance.  
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RESULTS 
 
 	   Daily PTZ injections result in kindling without impairments in body weight  
 Our modified PTZ protocol, in which we injected mice with the chemoconvulsant 
once a day for 10 days, resulted in chemical kindling as was noted previously in other 
references. Over the course of 10 days, the same dosage (30 mg/kg) of PTZ created more 
severe seizures, as seen in Figure 6. On the first day of injections, 50% of mice tested 
scored a 3 of higher on the scale of seizure severity (see Methods), which denotes a 
convulsive seizure. Days 2-5 resulted in roughly 75% of mice having a convulsive 
seizure. By day 7, 100% of animals were having convulsive seizures after the same 
dosage of PTZ injection (Figure 7). To obtain a quantitative measure of general well 
being, body weight was measured on alternate days during the 10-day paradigm and was 
found to be no different between PTZ and saline treated animals (Figure 8).   
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Figure 6: Seizure Severity Scores. Seizure scores (scaled 1-4) were recorded and  
compared over the 10 days for all animals that received PTZ.  
 
Figure 7: Evidence of Kindling. On day 1, 50% of animals displayed a convulsive 
seizure scoring 3 or higher. Days 2-4, roughly 75% of animals had a convulsive seizures. 
By day 7, 100% of animals scored a 3 or higher on the seizure severity scale, which 
represents the kindling phenomenon.  
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Figure 8: Weight Measurements. The weight of the mice in grams remained relatively 
constant throughout the 10 days except that by day 9, the PTZ mice weight slightly more 
than mice that only received saline.  
 
Post-seizure social behavior in mice was impaired  
 24-hours following 10 days of PTZ injections and associated seizures, male mice 
displayed impairments in social preference during the 3-chamber social test that 
continued to be present 30 days following the termination of the 10 day PTZ protocol. 
Specifically, we compared the interaction time, in seconds, of mice with the stranger 
mouse to the time spent with the empty cage. On day 11, while saline-injected mice spent 
significantly more time interacting with the stranger mouse than the empty cage, PTZ 
treated mice did not display a significant social preference (Figure 9). To examine 
whether this effect was associated with a confounding locomotor effect, we measured the 
distance moved during either trial.  
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On day 11, the mice that received seizures displayed an approximately 10-20% 
reduction in overall locomotor activity during both acclimation and social trials. Similar 
results were obtained in females. However, by day 40, no obvious differences in 
locomotion were observed in PTZ treated mice. These findings are depicted in Figures 9 
and 10.  
Figure 9: Male Social Behavior. Male mice that received PTZ showed no preference for 
social interaction at day 11 and day 40. These mice moved significantly less on day 11, 
but moved the same distance once re-tested at day 40.  
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Figure 10: Female Social Behavior. Female mice moved at the same distance compared 
to control mice, but presented with significant decreased social interaction scores at days 
11 and 40 following recurrent seizures.   
 
10 PTZ-Induced seizures result in ultrasonic vocalization deficits in both males and 
females 
We compared the number of ultrasonic vocalizations as well as the mean duration 
of these vocalizations emitted during the 5-minute trial in animals that received saline 
and PTZ injections. Male mice were paired with an unfamiliar female mouse and USV 
measurements were made. PTZ-treated mice emitted significantly fewer USVs when 
exposed to females. When PTZ-treated male mice did emit USVs, they were significantly 
shorter in duration than those emitted by male mice that received only saline injections 
(Figure 11).  
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Figure 11: Male USV Recordings. Male mice vocalized significantly less and for a 
shorter amount of time after being exposed to recurrent seizures compared to control 
mice 
 
Female mice exposed to seizures also emitted significantly fewer USVs than 
female mice that had only received saline injections. However, the mean duration (ms) of 
the USVs was not significantly different between the two groups (Figure 12).   
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Figure 12: Female USV Recordings. Female mice exposed to recurrent seizures 
exhibited fewer USV events than those who only received saline treatments. The duration 
of these events did not differ significantly between groups.  
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Olfaction was not significantly impaired in mice that received seizures 
 The buried food test was used as a screen for significant olfactory impairment 
following PTZ injections. No differences were observed in the time to find the buried 
food item in either males or females exposed to the 10 day PTZ protocol (Figure 13).    
 
 
Figure 13: Time to Food. In both male and female mice, the time it took for mice to find 
the buried food was not significantly different between groups that received seizures and 
controls.  
 
 
The 10-day PTZ Protocol results in mild reductions in locomotor activity, but not 
exploratory behavior on the open field test  
 
 The open field test was employed to gather a measure of exploratory behavior and 
as a second independent measure of locomotion. During the open-field test, male mice 
that had received seizures showed slight deficits in their locomotor abilities as measured 
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by total distance moved (cm) (Figure 14), mean velocity (cm/s) (Figure 15), percent time 
in center (Figure 15), and distance moved (cm) (Figure 16). On day 11, mice that 
received PTZ ambulated similar distances to those mice receiving saline alone. In 
contrast, the total time spent in the center of the arena (a measure of their exploration or 
risk-taking behavior) was not changed in comparison to controls. Figure 17 depicts the 
average mobility of mice that received seizures, which was not significantly different 
from mice that did not have seizures.  
 
Figure 14: Distance Moved in Open Field. Mice that experienced recurrent seizures 
post-PTZ injections moved less than mice that received saline across all 60-second 
intervals (bins) except the first 60 seconds.  
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Figure 15: Mean Velocity and Time in Center. Left: Mice moved at a significantly 
slower pace (cm/s) after receiving injections of PTZ compared to saline. Right: In both 
groups, mice spent similar periods of time exploring the center of the open field. 
 
 
Figure 16: Total Distance Moved. Mice exposed to PTZ moved significantly less (cm) 
than mice that only received saline during the open field task.  
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Figure 17: Mobility Map. Mice that received PTZ exhibited similar patterns of 
movement and spent a comparable percentage of the time in the center.  
  
Saline	   PTZ	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DISCUSSION 
 	   Based on the observation that comorbid epilepsy appears to worsen the 
progression of autism spectrum disorders, our goal in this study was to establish a mouse 
model to observe the impact of recurrent seizures on social behavior relevant to the study 
of autism. In humans, many groups have shown that epilepsy tends to worsen the severity 
of many autism characteristics and may also act to generate autistic-like symptoms 
(Bolton et al., 2011; Wakeford et al., 2014; Spence and Schneider, 2009). While other 
investigators have demonstrated social deficits in mice exposed to either early life 
seizures (Lugo et al., 2014), or recurrent spontaneous seizures occurring following status 
epilepticus (Seo et al., 2013), this was the first study of its kind to demonstrate the 
presence of lasting social deficits using the PTZ model. We addressed several key areas 
of social behavior and propose that this new model may serve as a useful tool to 
investigate the molecular relationship between seizures and social behavior.  
 Are PTZ injections relevant to the study of epilepsy? Recurrent seizures induced 
by PTZ only mimic the recurrent seizures that come about in epilepsy, but do not mimic 
the tendency to display spontaneous unprovoked seizures, that can be seen using other 
chemoconvulsant models such as pilocarpine- induced status epilepticus. These latter 
models may be better suited to study the process of epileptogenesis and genetic 
modulators of seizure frequency and spread. In contrast, the generation of seizures with 
PTZ may be better suited to study the molecular and behavioral neuroplasticity associated 
with seizures themselves. Typically, PTZ injections are administered every 48 hours. In 
contrast, our protocol used PTZ injections daily for 10 days. We chose to follow this 
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protocol because we found that we could create a faster, yet accurate model of kindling 
with minimal animal mortality. During preliminary testing (not shown above), we 
observed that for this genetic background of mice, the dosage of 30mg/kg was sufficient 
to result in chemical kindling with a large number of convulsive seizures without a 
significant mortality rate. Mice subjected to such daily subconvulsant daily PTZ 
injections displayed a progressive increase in their seizure severity score, mimicking the 
similar kindling phenomena observed in other models of repeated chemoconvulsant 
administration. We did not observe any obvious spontaneous seizures or status 
epilepticus, and our mortality rate was quite reasonable (10-20%). Experiments in our 
laboratory are currently under way to investigate the EEG patterns of PTZ-induced 
seizures in our strain of mice, as well as to closely examine their EEG in between PTZ 
injections to ensure that no spontaneous seizures are observed. 
 Social deficits are seen in a variety of ways in patients with autism or epilepsy as 
well as individuals that have both autism and epilepsy. Many of these deficits are 
debilitating and seem to be worse in individuals that suffer from comorbid disorders or 
syndromes. In order to determine whether this phenomenon is directly related to the 
seizures themselves, we tested the animals on the 3-chamber social task 24-hours 
following 10 days of PTZ injections. Based on results from similar experiments (Seo et 
al., 2013), we hypothesized that animals exposed to seizures would lose their social 
preference and that the saline treated animals would retain their preference for social 
interaction. We observed this phenomenon not only at day 11, but also thirty days 
following their last seizure (Day 40). Thus, the social deficit as measured in the 3-
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chamber task seems to remain well after the seizures have concluded. In the 3-chamber 
task, we did observe a subtle but significantly lower distance moved on Day 11 in mice 
exposed to PTZ injections, which we confirmed was also present on the open field test. 
Thus, the question arises about whether; at least in male mice on Day 11, their impaired 
social behavior is simply a reflection of diminished motor activity. We believe that this is 
not likely to be the case for several reasons. First, on Day 11, we observed no significant 
correlation between distanced moved and interaction times for the empty cage or 
stranger. Second, on the open field test, we observed no impairments in exploratory 
behavior, suggesting that this phenotype is not related merely to a heightened anxiety-like 
phenotype. Third, on day 40, when PTZ treated mice continue to display a social 
phenotype, their distances moved were similar to saline-treated animals, suggesting that 
this slight reduction in locomotion likely represents a nonspecific transient effect of 
recent PTZ exposure that is not causatively linked to changes in social interaction or 
exploration. In the future it would be beneficial to monitor these mice with EEG and 
perhaps alternative motor function testing such as the Morris water maze or the Rotarod. 
It would also be advantageous to come back and test these animals again at later dates to 
see if the social deficit is maintained after the initial seizure period and after 40 days or to 
extend the seizure protocol to 15 or 20 days to observe the effects of a longer seizure 
period on social behavior. 
 We used ultrasonic vocalization measurements to observe whether mice exposed 
to seizures presented with deficits in communication that are often seen in human autism 
(Kelley et al., 2006). We expected to see deficits in vocalizations in both male and female 
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mice following exposure to repeated seizures. We saw a reduction in the total number of 
vocalization events over the course of 5 minutes in both male and female mice. In male 
mice that were exposed to females, we also saw a reduction in the mean duration (ms) of 
those events. Studying male vocalizations in response to a female, and studying 
vocalizations between unfamiliar female counterparts are fundamentally different 
phenomena: male mice vocalize predominantly in response to a sexual scenario involving 
the presence of females or their urine (Smith et al., 2011; Portfors, 2007). Female mice 
vocalize in response to other females in a purely social context (Smith et al., 2011, 
Portfors, 2007). It is possible that the different contexts of eliciting vocalization could 
have an impact on the number and duration of the USV events, but a recent study 
suggests that vocalizations are essentially very similar and only showed minor 
differences, but still conveyed an accurate portrayal of social behaviors (Hammerschmidt 
et al., 2012). During the experiment, it appeared that the USV events began immediately 
after contact with the mouse was established with the stranger. It was difficult to close the 
box and start recording immediately after the mice began to interact. In the future, it 
would be favorable to find a way to start recording immediately in order to get the most 
complete picture possible of the number of events and duration of events.  
 Olfactory cues in mammals have long been established to be crucial for normal 
social behavior, especially in rodents (Doty, 1986). These cues are also particularly 
important for sexual-social behaviors (Restrepo et al., 2004, Keverne, 2004). In order to 
rule out the possibility that our wild type mice possessed any sort of olfactory deficit, 
which would have affected their social behavior, we conducted the buried food test that 
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was created to ensure a properly function vomeronasal system (Yang and Crawley, 
2009). Upon reviewing our data, the majority of mice found the food well within the time 
constraints of 15 minutes; however, we excluded mice that took over 600 seconds to find 
the food. We found that the wild type animals that were exposed to seizures possessed 
normal olfactory capabilities as tested during the buried food test. There was some 
variability in the duration taken to find the food, but nothing significantly out of the 
ordinary abilities of wild type mice. We used chocolate chip teddy grahams as the treat 
that the mice were supposed to find buried in their cage, which was suggested as a well-
liked snack (Yang and Crawley, 2009). In the future, it would be helpful to find a treat 
that was extremely desirable across the spectrum of mice that we work with in order to 
provide proper motivation to find the food as quickly as possible.  
 The open field test was used to examine both the locomotor capabilities and 
anxiety behaviors of these wild type mice. It was important that our mice not display 
locomotor deficits, which could have negatively impacted their social interactions pre-or 
post-seizure. The data we gathered from the open-field test allowed us to conclude that 
the mice treated with PTZ actually did show some deficits in movement. Overall, mice 
that had seizures moved less and at a slower rate than mice that received saline injections. 
Both sets of mice spent comparable amounts of time exploring the center of the box. 
There are many ways to analyze what this data means, but no definitive way of 
determining whether this finding negatively impacted their social interactions. Both 
saline and PTZ treated mice spent equivalent amounts of time in the center of the arena, 
suggesting that impairment in social interaction may not be simply a result of diminished 
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exploration.  
 In order to explore the results of the open field test further, multiple other 
locomotor tests should be conducted, but also tests that look at the effects of the exposure 
to PTZ itself. PTZ acts as a GABAA receptor antagonist and has been used as a kindling 
agent for years (Dhir et al., 2012). GABAA receptors are part of the ionotropic receptor 
family that includes NMDA and AMPA receptors (Ben-Ari et al., 1997). Previous studies 
have shown that locomotor activity assessed by the open field test was hindered by 
administration of NMDA and AMPA antagonists (Danysz et al., 1994). Although this 
experiment did not directly test the effects of PTZ on locomotion, it would be worth 
examining the effects of PTZ alone on the locomotor activities of mice in order to further 
explore our kindling model using PTZ to study the connection between epilepsy and 
autism.  
 Other potential areas of study to further our hypotheses should build on the 
premise that previous studies have shown that epilepsy can create deficits in memory due 
to death of neurons and synaptic reorganization in the hippocampus and other brain 
regions (Holmes, 2002; Lado et al., 2002). Our lab has used social memory tasks in the 
past to ensure the mice do not have deficits in memory that might cause the apparent lack 
of social preference we saw in our mice. In the future, we will incorporate this type of 
testing after the seizure protocol to ensure this was not a factor. Other future experiments 
could be done using magnetic resonance imaging (MRI) to study the structure of the 
brains of mice that have been exposed to this sort of seizure protocol. Structural 
abnormalities in the hypothalamus, striatum, parieto-temporal lobe, cerebellar cortex, and 
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frontal lobe were observed across 26 different mouse models of autism. The mice in this 
study were grouped into categories of structural abnormalities by region and whether they 
displayed over or under-connectivity within the synaptic region (Ellegood et al., 2015). It 
would be interesting to ascertain whether these mice with epilepsy and social deficits had 
similar structural abnormalities, if any. Studies have also been done to determine whether 
epilepsy itself creates lasting structural deficits in the brain, mainly cerebral, 
hippocampal, or cerebellar atrophy (Duncan, 2002); however, those studies were 
conducted over the course of 3.5 years in humans and have not been replicated.  
 This PTZ model is also aptly suited to study individual differences in response to 
seizures. Taken as a group, mice treated with PTZ on average had similar interaction 
times between a stranger mouse and the empty cage. We did, however, observe some 
variability in this phenomenon, with some animals continuing to display a social 
preference and others displaying a relative social avoidance. Studying the biological basis 
of this type of variation in response may provide clues about specific biological 
mediators of vulnerability to seizure-induced impairments in social behavior (Krishnan et 
al., Cell 2007).  
It would also be helpful to address the third key behavior of the autism diagnosis: 
highly repetitive behaviors. In the future, it would be nice to add this test to our repertoire 
of investigation into the effects of seizures on behavior in order to generate a more 
complete model. To address some of these aspects, specific tests of learning and memory 
could be helpful due to the relationship between IQ and autism and epilepsy seen in 
humans (Caplan & Austin, 2000). It is possible to assess the general learning abilities of 
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mice to evaluate each individual mouse’s capacity for common tasks (Matzel et al., 
2003). Determining individual differences in these mice could explain some aspect of the 
variety of results we see during behavioral tests.  
 This body of work gives us a small insight into the complex field of epilepsy and 
social behavior, which seems to be becoming more important each day as more people 
are affected by both autism and epilepsy. Many clues have led us to the fact that seizures 
may be directly affecting the social behavioral outcomes of patients, but the relationship 
between the two has still not been definitely established. Mice that have been exposed to 
recurrent seizure present with impaired social behaviors that are autistic-like in nature. 
Using accepted models of human disorders, we were able to show seizures alone are 
sufficient to recreate these deficits in a lasting manner. There are still several aspects of 
these tests and relationships that need to be improved upon and addressed, but these 
findings are a step in the right direction in order to find the link, whether it be structural, 
genetic, or some other unknown cause, between autism and epilepsy. 
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